Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Classys (214150 KS): Equipment Sale Boosts 2Q Result; New Device Approval to Drive 2H Performance

Classys (214150 KS): Stellar 3Q Result; 2025 Guidance Reaffirmed; Brazil Is Set to Recover from 4Q

Classys (214150 KS): Solid Start to 2025; Global Expansion Continues; Stake Sale Overhang to Remain

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/classys" target="_blank" data-smartkarma-citation="entities:29688:1" rel="noopener">Classys (214150 KS)</a> reported 4Q25 revenue and operating profit of KRW93B and KRW51B, up 26% and 43%, YoY, respectively. Overseas sales grew 33% YoY, driven by both devices and consumables.</li>
<li>2025 revenue growth of 38% YoY exceeds the average growth rate over the past three years. Despite increased depreciation expenses due to the Ilooda merger, Classys maintained industry-leading profitability.</li>
<li>Classys has guided for 2026 revenue of KRW470–510B, up 40–51% YoY, accelerated from 39% YoY revenue growth reported in 2025. China will be a strategic long-term growth opportunity.</li>
</ul>



Classys (214150 KS) reported 4Q25 revenue and operating profit of KRW93B and KRW51B, up 26% and 43%, YoY, respectively. Overseas sales grew 33% YoY, driven by both devices and consumables.
2025 revenue growth of 38% YoY exceeds the average growth rate over the past three years. Despite increased depreciation expenses due to the Ilooda merger, Classys maintained industry-leading profitability.
Classys has guided for 2026 revenue of KRW470–510B, up 40–51% YoY, accelerated from 39% YoY revenue growth reported in 2025. China will be a strategic long-term growth opportunity.


Classys (214150 KS): Global Expansion Leads Record High Performance in 4Q; 2026 Guidance Initiated